AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 28869786
Drug: 1.2 mg
RxNorm normalized name: RNA 1.2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 mg dose of lorazepam
Trial: 21062137
Drug: Aliskiren/valsartan 300/320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren/valsartan 300/320 mg
Trial: 15986954
Drug: Prompt L‐Pop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prompt L‐Pop + SureFil with flowable resin composite
Trial: 12682621
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose losartan (100 mg/day)
Trial: 10726921
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg vanadyl sulfate (VOSO4)
Trial: 10726921
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg vanadyl sulfate (VOSO4)
Trial: 10726921
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg and 300 mg vanadyl sulfate (VOSO4)
Trial: 8934373
Drug: Lacidipine (2-6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lacidipine (2-6 mg)
Trial: 1527233
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg orally followed by adinazolam 30 mg 1 hour later (treatment A)
Trial: 1527233
Drug: Adinazolam alone
RxNorm normalized name: adinazolam
DrugBank: Adinazolam (DB00546)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adinazolam alone (treatment B)
Trial: 4014629
Drug: Intravenous meptazinol
RxNorm normalized name: meptazinol
DrugBank: Meptazinol (DB13478)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous meptazinol 2 mg/kg
Trial: 17657327
Drug: Usual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual therapy (TH)
Trial: 29081977
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no statin therapy)
Trial: 22072154
Drug: Entecavir therapy
RxNorm normalized name: Entecavir
DrugBank: Entecavir (DB00442)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Entecavir therapy (4 doses)
Trial: 18460701
Drug: Candesartan cilexitil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexitil 16 mg
Trial: 8701872
Drug: Probucol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probucol (0.5 mg/day) administered between >7 days before PTCA and 3 months after PTCA
Trial: 8701872
Drug: Probucol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probucol (0.5 mg/day)
Trial: 1341324
Drug: Surgery followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Surgery followed by chemotherapy and selective radiotherapy to the brain for stage pT1-3N0M0 patients.
Trial: 1341324
Drug: Surgery followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Surgery followed by chemotherapy for stage pT1-3N2M0 patients.
Trial: 1341324
Drug: Initial surgery
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial surgery for resectable tumors followed by postoperative chemotherapy.
Trial: 1341324
Drug: Preoperative chemotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative chemotherapy followed by adjuvant surgery.
Trial: 29294732
Drug: Group Cognitive-Behavioral
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group Cognitive-Behavioral Therapy (GCBT)
Trial: 30025255
Drug: Fluoxetine (FLX)
DrugBank: Fluoxetine (DB00472)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluoxetine (FLX) and GCBT
Trial: 11518201
Drug: Margarine enriched
RxNorm normalized name: MARGARINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Margarine enriched with 1.5 g/d plant sterols
Trial: 11518201
Drug: Margarine enriched
RxNorm normalized name: MARGARINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Margarine enriched with 3.0 g/d plant sterols
Trial: 7687364
Drug: DSG low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DSG low dose
Trial: 7687364
Drug: DSG high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DSG high dose
Trial: 24504100
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid (4 mg IV every 3 months for 24 months)
Trial: 20071999
Drug: Vicriviroc 5
RxNorm normalized name: Vicriviroc
DrugBank: Vicriviroc (DB06652)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vicriviroc 5 mg once daily
Trial: 20071999
Drug: Vicriviroc 10
RxNorm normalized name: Vicriviroc
DrugBank: Vicriviroc (DB06652)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vicriviroc 10 mg once daily
Trial: 20071999
Drug: Vicriviroc 15
RxNorm normalized name: Vicriviroc
DrugBank: Vicriviroc (DB06652)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vicriviroc 15 mg once daily
Trial: 20672447
Drug: Vicriviroc (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vicriviroc (all doses)
Trial: 23415311
Drug: Lurasidone 80
RxNorm normalized name: lurasidone 80 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lurasidone 80 mg
Trial: 7823546
Drug: 4-hour hydration
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4-hour hydration treatment
Trial: 7823546
Drug: 4-hour dehydration
RxNorm normalized name: Dehydrated Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 4-hour dehydration treatment
Trial: 7823546
Drug: 4-hour placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4-hour placebo (control) treatment
Trial: 28593789
Drug: Proton pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton pump inhibitors
Trial: 31182528
Drug: GSK3036656 single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK3036656 single doses of 5 mg (fed and fasted), 15 mg, and 25 mg; placebo as control
Trial: 31182528
Drug: GSK3036656 repeat
RxNorm normalized name: Tricontanyl Povidone (4 Tricontanyl Branches/Repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK3036656 repeat doses of 5 mg and 15 mg; placebo as control
Trial: 31182528
Drug: GSK3036656 (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK3036656 (both single and multiple doses)
Trial: 27424014
Drug: Topical nitroglycerin
RxNorm normalized name: nitroglycerin Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical nitroglycerin (Group A)
Trial: 27424014
Drug: Topical diltiazem
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical diltiazem (Group B)
Trial: 27424014
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (Group C)
Trial: 23359967
Drug: ATRA combined
RxNorm normalized name: ATRA
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ATRA combined with Compound Huangdai Tablet
Trial: 20028919
Drug: Interferon (intermediate-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon (intermediate- versus low-dose)
Trial: 11953279
Drug: Inhalative mucolytic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalative mucolytic drug mercapto‐ethane sulfonate (Mesna)
Trial: 8669222
Drug: Mivacurium 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mivacurium 0.15 mg/kg (group A)
Trial: 8669222
Drug: Mivacurium 0.17
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mivacurium 0.17 mg/kg (group B)
Trial: 8669222
Drug: Mivacurium 0.19
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mivacurium 0.19 mg/kg (group C)
Trial: 31511080
Drug: Initial combination
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial combination therapy with ambrisentan 10 mg plus tadalafil 40 mg
Trial: 31511080
Drug: Pooled monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pooled monotherapy (ambrisentan 10 mg plus placebo or tadalafil 40 mg plus placebo)
Trial: 18759737
Drug: Tertiary individual
RxNorm normalized name: Prednisolone tertiary butylacetate
DrugBank: Prednisolone tebutate (DB14632)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tertiary individual prevention (TIP) - 3 weeks inpatient treatment including intensive health care instruction and psychological counseling, followed by outpatient treatment by the local dermatologist.
Trial: 24037015
Drug: Oral Appliance
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral Appliance
Trial: 15060873
Drug: Ketodiet (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketodiet (0.3 g/kg/d protein plus tablets of KAs)
Trial: 15060873
Drug: Placebo (0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0.6 g/kg/d protein plus placebo)
Trial: 11552770
Drug: Reboxetine add
RxNorm normalized name: REBOXETINE
DrugBank: Reboxetine (DB00234)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reboxetine add on to haloperidol 5 mg
Trial: 11552770
Drug: Placebo add
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo add on to haloperidol 5 mg
Trial: 3125882
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg aspirin daily
Trial: 28242866
Drug: Mitiglinide (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitiglinide (10 mg) and Voglibose (0.2 mg) (M+V) 3 times daily
Trial: 28242866
Drug: Dipeptidyl Peptidase-4
RxNorm normalized name: Immature tripeptidyl-peptidase I
DrugBank: Cerliponase alfa (DB13173)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Dipeptidyl Peptidase-4 Inhibitor (Linagliptin 5 mg) (L) once daily
Trial: 28242866
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (M+V and L)
Trial: 18974657
Drug: Antibiotic ointment
RxNorm normalized name: CVS Antibiotic Ointment
DrugBank: Polymyxin B (DB00781)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antibiotic ointment (AO) prophylaxis
Trial: 18974657
Drug: Catheter antimicrobial
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Catheter antimicrobial locking (AL) with heparin + gentamicin (5.2 mg/ml)
Trial: 12915429
Drug: Standard-dose guggulipid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose guggulipid (1000 mg)
Trial: 12915429
Drug: High-dose guggulipid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose guggulipid (2000 mg)
Trial: 12915429
Drug: Guggulipid (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guggulipid (both doses)
Trial: 1539474
Drug: Thiopentone 4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopentone 4.5 mg.kg‐1
Trial: 3886394
Drug: Binedaline 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Binedaline 100 mg (females) and 150 mg (males)
Trial: 3886394
Drug: Amitriptyline 50
RxNorm normalized name: amitriptyline 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline 50 mg and 75 mg
Trial: 24698126
Drug: Local heat
RxNorm normalized name: norethindrone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Local heat therapy
Trial: 29457317
Drug: Alcohol infusion
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol infusion (0.08% blood alcohol level)
Trial: 27416664
Drug: Dapoxetine 30
RxNorm normalized name: duloxetine 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapoxetine 30 mg qd
Trial: 27416664
Drug: Control (Tamsulosin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Tamsulosin 20 mg qd)
Trial: 23606682
Drug: COBRA therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COBRA therapy (prednisolone 60 mg/day, tapered to 7.5 mg/day in 6 weeks, methotrexate 7.5 mg/week, sulfasalazine 2 g/day)
Trial: 23606682
Drug: COBRA-light therapy
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COBRA-light therapy (lower dose prednisolone starting at 30 mg/day, tapered to 7.5 mg/day in 9 weeks, methotrexate escalated to 25 mg/week in 9 weeks)
Trial: 16049639
Drug: Alanyl-glutamine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alanyl-glutamine (0.5 g x kg(‐1) x day(‐1) of undiluted alanyl‐glutamine (20%))
Trial: 7728369
Drug: Biperiden (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biperiden (4 mg/day)
Trial: 1674835
Drug: Active TENS
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active TENS during treatment and active TENS during stress
Trial: 1674835
Drug: Active TENS
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active TENS during treatment and placebo TENS during stress
Trial: 1674835
Drug: Placebo TENS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo TENS during treatment and placebo TENS during stress
Trial: 1674835
Drug: Placebo TENS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo TENS during treatment and active TENS during stress
Trial: 1674835
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment during both treatment and stress
Trial: 6110504
Drug: Indenolol 40,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indenolol 40, 80, 160, and 320 mg
Trial: 6110504
Drug: Propranolol 40,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 40, 80, 160, and 320 mg
Trial: 6734921
Drug: Buflomedil 600
RxNorm normalized name: buflomedil 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buflomedil 600 mg/day orally
Trial: 27555505
Drug: Higher weekly
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Higher weekly alcohol consumption
Trial: 27555505
Drug: Diuretic use
RxNorm normalized name: benazepril and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretic use in participants with chronic kidney disease
Trial: 18707117
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g of collagen hydrolysate (CH) in 100 mL of fermented milk product (FMP)
Trial: 18707117
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g of collagen hydrolysate (CH) dissolved in 100 mL of water (neat hydrolyzed collagen)
Trial: 11570641
Drug: Anti-IL-6 monoclonal
RxNorm normalized name: HUMAN ANTI-IL-6 MONOCLONAL ANTIBODY (PF-04236921)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-IL-6 monoclonal antibody (1 microg/ml)
Trial: 11570641
Drug: Anti-IL-10 monoclonal
RxNorm normalized name: Anti-VEGF monoclonal antibody
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Anti-IL-10 monoclonal antibody (1 microg/ml)
Trial: 11570641
Drug: Combined anti-IL-6
RxNorm normalized name: IL-6
DrugBank: Human interleukin-6 (DB15060)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined anti-IL-6 and anti-IL-10 monoclonal antibodies (each at 1 microg/ml)
Trial: 24565750
Drug: 0.15mmol/kg contrast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15mmol/kg contrast agent
Trial: 20798988
Drug: Nurse-administered education
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nurse-administered education program (Group 1)
Trial: 20798988
Drug: Nurse-administered education
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nurse-administered education program with additional pharmacist counseling (Group 2)
Trial: 9585279
Drug: Epinephrine (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epinephrine (0.2 mg)
Trial: 9585279
Drug: Bupivacaine (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (7.5 mg) without epinephrine
Trial: 30903614
Drug: Monthly household
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly household income
Trial: 9170825
Drug: Dinoprostone vaginal
RxNorm normalized name: dinoprostone Vaginal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dinoprostone vaginal tablets
Trial: 22057947
Drug: Treatment A
RxNorm normalized name: Nix Ultra Lice Treatment And Prevention Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment A (600 IU eCG on Day 4 after CIDR insertion)
Trial: 22057947
Drug: Treatment B
RxNorm normalized name: PanOxyl Acne Treatment Bar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment B (300 IU eCG at the same time)
Trial: 22057947
Drug: Treatment C
RxNorm normalized name: Acne Treatment Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment C (250 IU FSH on Day 4 post-insertion)
Trial: 19155993
Drug: Aciclovir 400
RxNorm normalized name: Aciclovir 400 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aciclovir 400 mg twice daily for 3 months
Trial: 15744902
Drug: Panax notoginseng
RxNorm normalized name: PANAX NOTOGINSENG TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Panax notoginseng (PNG) 1,350 mg per day for 30 days
Trial: 15744902
Drug: Starch capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Starch capsule (control) 1,350 mg per day for 30 days
Trial: 16305977
Drug: valsartan 160
RxNorm normalized name: valsartan 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: valsartan 160 mg/day
Trial: 11991217
Drug: captopril 100
RxNorm normalized name: captopril 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: captopril 100 mg/day
Trial: 11991217
Drug: combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: combined therapy (valsartan + captopril)
Trial: 7539853
Drug: Doxazosin (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin (8 mg once daily)
Trial: 2181787
Drug: Telenzepine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telenzepine (3 mg in the morning)
Trial: 382150
Drug: Domperidone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone (10 mg t.d.s.)
Trial: 339141
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg water-soluble bioflavonoids and 600 mg ascorbic acid, administered three times daily
Trial: 339141
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg water-soluble bioflavonoids and 1000 mg ascorbic acid, administered five times daily
Trial: 26620248
Drug: Dapagliflozin 10
RxNorm normalized name: dapagliflozin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapagliflozin 10 mg once a day
Trial: 30601059
Drug: Positive Strategies
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive Strategies To Enhance Problem‐solving Skills (Positive STEPS) intervention, which includes five individual counseling sessions and daily text message reminders.
Trial: 19769016
Drug: Contemplative/preparation group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contemplative/preparation group
Trial: 11498062
Drug: 0.12% zinc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.12% zinc sulfate nasal spray administered as two inhalations in each nostril four times a day
Trial: 11498062
Drug: Isotonic placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic placebo spray
Trial: 4016543
Drug: Augmentin (1.2g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Augmentin (1.2g intravenously pre-operatively, with 8 additional doses for gangrenous or perforated appendices)
Trial: 4016543
Drug: Metronidazole (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (500 mg intravenously pre-operatively, with 8 additional doses for gangrenous or perforated appendices)
Trial: 30058572
Drug: Rituximab plus
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab plus chemotherapy (R-chemo)
Trial: 26233481
Drug: Aclidinium/formoterol 400/12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aclidinium/formoterol 400/12 μg
Trial: 25404569
Drug: Aclidinium/formoterol 400/6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aclidinium/formoterol 400/6 μg
Trial: 23091141
Drug: Dietary supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary supplementation of 2.5 g/kg LFA
Trial: 23091141
Drug: Dietary supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary supplementation of 5.0 g/kg LFA
Trial: 2104735
Drug: Inhaled ergotamine
RxNorm normalized name: ergotamine tartrate Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled ergotamine tartrate (1 puff, 0.36 mg)
Trial: 1324238
Drug: Itraconazole 100
RxNorm normalized name: itraconazole 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole 100 mg/day
Trial: 8647515
Drug: Itraconazole 400
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Itraconazole 400 mg/day
Trial: 28603868
Drug: Postoperative block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative block with 0.5 ml.kg‐1 ropivacaine 0.75%
Trial: 26014587
Drug: Transdermal donepezil
RxNorm normalized name: donepezil Transdermal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal donepezil patch 87.5 mg/25 cm(2) every 72 h
Trial: 26014587
Drug: Transdermal donepezil
RxNorm normalized name: donepezil Transdermal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal donepezil patch 175 mg/50 cm(2) every 72 h